Obatoclax was originally described as a BH3 mimetic, which functions by binding antiapoptotic BCL-2 family proteins for displacing bound BH3-only proteins to initiate BAX/BAK-dependent apoptosis in cancer cells [35]. The gene discussed is BCL2; the disease is cancer.